CALYPTE BIOMEDICAL

CALYPTE BIOMEDICAL

Calypte Biomedical Corporation develops in vitro diagnostic testing solutions for HIV and other infectious diseases. Its current product portfolio includes tests for the diagnosis and surveillance of HIV and sampling systems.
Products

Recently updated

Rapid Drugs of Abuse Tests
aware Cocaine/Morphine/THC Triple Test

The aware Cocaine/Morphine/THC Triple Test is a rapid qualitative immunochromatographic assay with competitive binding principle for the simultaneous detection of cocaine, morphine, cannabinoids and their metabolites in human urine sample. The test is only one step and easy to use, while the test result can be read by the naked eye within five minutes without the need for any instrument to perform the test.
More details

HIV Test
AWARE BED EIA TEST

The AWARE BED EIA HIV-1 incidence EIA test is an in vitro quantitative enzyme immunoassay that estimates the incidence by determining the proportion of HIV-1 specific IgG in a given serum, plasma or whole-blood specimen compared to total IgG. The test is compatible both liquid and dried samples, with a Dried Blood Spot or DBS Control Pack available separately that is needed to test dried plasma, serum or whole blood samples.
More details

Oral Fluid Collection Device
Aware Messenger

The Aware Messenger oral fluid collection device is intended for the collection, stabilization, and transport of high quality oral fluid specimens to be used for the detection of specific antibodies or other analytes. The device enables the use of oral fluid samples, which are easy to collect and transport, with laboratory-based assays offering high throughput batch processing, automation, quantitative results, and lower costs.
More details

Clinical Laboratory

Rapid Drugs of Abuse Tests
aware Cocaine/Morphine/THC Triple Test

The aware Cocaine/Morphine/THC Triple Test is a rapid qualitative immunochromatographic assay with competitive binding principle for the simultaneous detection of cocaine, morphine, cannabinoids and their metabolites in human urine sample. The test is only one step and easy to use, while the test result can be read by the naked eye within five minutes without the need for any instrument to perform the test.
More details

HIV Test
AWARE BED EIA TEST

The AWARE BED EIA HIV-1 incidence EIA test is an in vitro quantitative enzyme immunoassay that estimates the incidence by determining the proportion of HIV-1 specific IgG in a given serum, plasma or whole-blood specimen compared to total IgG. The test is compatible both liquid and dried samples, with a Dried Blood Spot or DBS Control Pack available separately that is needed to test dried plasma, serum or whole blood samples.
More details

Oral Fluid Collection Device
Aware Messenger

The Aware Messenger oral fluid collection device is intended for the collection, stabilization, and transport of high quality oral fluid specimens to be used for the detection of specific antibodies or other analytes. The device enables the use of oral fluid samples, which are easy to collect and transport, with laboratory-based assays offering high throughput batch processing, automation, quantitative results, and lower costs.
More details

Immunoassay Test
AWARE HIV-1/2 OMT

The AWARE HIV-1/2 OMT (oral fluid) test is a single-use, qualitative, visually read, in vitro immunoassay for the detection of antibodies to HIV Type 1 (HIV-1) and Type 2 (HIV-2) in human oral fluid specimens (oral mucosal transudate). The test is intended for use as a point-of-care aid in the clinical diagnosis of HIV infection and can also be used as a component of a multi-test algorithm in conjunction with other approved HIV-antibody assays, including other rapid tests.
More details
Copyright © 2000-2025 TradeMed.com. All rights reserved. | Terms And Conditions